D. Valeyre, A. Prasse, H. Nunes, Y. Uzunhan, P. Brillet et al., Sarcoidosis, The Lancet, vol.383, issue.9923, pp.1155-1167, 2014.
DOI : 10.1016/S0140-6736(13)60680-7
URL : https://hal.archives-ouvertes.fr/hal-00273498

G. Gibson, R. Prescott, M. Muers, W. Middleton, D. Mitchell et al., British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment., Thorax, vol.51, issue.3, pp.238-247, 1996.
DOI : 10.1136/thx.51.3.238

G. Rizzato, L. Montemurro, and P. Colombo, The late follow-up of chronic sarcoid patients previously treated with corticosteroids, Sarcoidosis Vasc Diffuse Lung Dis, vol.15, pp.52-58, 1998.

M. Iannuzzi, B. Rybicki, and A. Teirstein, Sarcoidosis, New England Journal of Medicine, vol.357, issue.21, pp.2153-2165, 2007.
DOI : 10.1056/NEJMra071714

E. Bargagli, D. Bennett, C. Maggiorelli, D. Sipio, P. Margollicci et al., Human Chitotriosidase: a Sensitive Biomarker of Sarcoidosis, Journal of Clinical Immunology, vol.3, issue.3, pp.264-270, 2013.
DOI : 10.1186/1465-9921-6-78

S. Miyoshi, H. Hamada, T. Kadowaki, N. Hamaguchi, R. Ito et al., Comparative Evaluation of Serum Markers in Pulmonary Sarcoidosis, Chest, vol.137, issue.6, pp.1391-1397, 2010.
DOI : 10.1378/chest.09-1975

M. Harlander, B. Salobir, M. Zupan?i?, M. Dolen?ek, B. Vodovnik et al., Serial chitotriosidase measurements in sarcoidosis ??? Two to five year follow-up study, Respiratory Medicine, vol.108, issue.5, pp.775-782, 2014.
DOI : 10.1016/j.rmed.2014.02.002

K. Takada, Y. Ina, M. Noda, T. Sato, M. Yamamoto et al., The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis, Journal of Clinical Epidemiology, vol.46, issue.4, pp.359-366, 1993.
DOI : 10.1016/0895-4356(93)90150-Y

N. Schoenfeld, B. Schmolke, M. Schmitt, R. N. Ellensohn, P. Wahn et al., Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis., Thorax, vol.49, issue.7, pp.688-691, 1994.
DOI : 10.1136/thx.49.7.688

Y. Kataria and J. Holter, IMMUNOLOGY OF SARCOIDOSIS, Clinics in Chest Medicine, vol.18, issue.4, pp.719-739, 1997.
DOI : 10.1016/S0272-5231(05)70415-9

F. Rømer and J. Sølling, Relationship between Circulating Immune Complexes and Angiotensin-Converting Enzyme in Pulmonary Sarcoidosis, Acta Medica Scandinavica, vol.13, issue.1-6, pp.299-303, 1981.
DOI : 10.1111/j.0954-6820.1980.tb01228.x

A. Tzouvelekis, G. Kouliatsis, S. Anevlavis, and D. Bouros, Serum biomarkers in interstitial lung diseases, Respiratory Research, vol.195, issue.1, pp.78-16042760, 2005.
DOI : 10.1002/path.892

G. Bouzillé, E. Sylvestre, B. Campillo-gimenez, R. E. Ledieu, T. Delamarre et al., An Integrated Workflow For Secondary Use of Patient Data for Clinical Research, Stud Health Technol Inform, vol.216, pp.913-26262215, 2015.

R. Baughman, S. Nagai, M. Balter, U. Costabel, M. Drent et al., Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force, Sarcoidosis Vasc Diffuse Lung Dis, vol.28, pp.56-64, 2011.

M. Judson, R. Baughman, B. Thompson, A. Teirstein, M. Terrin et al., Two year prognosis of sarcoidosis: the ACCESS experience, Sarcoidosis Vasc Diffuse Lung Dis, vol.20, pp.204-211, 2003.

J. Gottlieb, H. Israel, R. Steiner, J. Triolo, and H. Patrick, Outcome in Sarcoidosis, Chest, vol.111, issue.3, pp.623-631, 1997.
DOI : 10.1378/chest.111.3.623

M. Judson, Extrapulmonary Sarcoidosis, Seminars in Respiratory and Critical Care Medicine, vol.28, issue.1, pp.83-101, 2007.
DOI : 10.1055/s-2007-970335

M. Judson, U. Costabel, M. Drent, A. Wells, L. Maier et al., The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool, Sarcoidosis Vasc Diffuse Lung Dis, vol.31, pp.19-27, 2014.

R. Baughman and M. Judson, Relapses of sarcoidosis: what are they and can we predict who will get them?, European Respiratory Journal, vol.43, issue.2, pp.337-339, 2014.
DOI : 10.1183/09031936.00138913

P. Studdy, R. Bird, E. Neville, and D. James, Biochemical findings in sarcoidosis., Journal of Clinical Pathology, vol.33, issue.6, pp.528-533, 1980.
DOI : 10.1136/jcp.33.6.528
URL : http://jcp.bmj.com/content/jclinpath/33/6/528.full.pdf

L. Siltzbach, D. James, E. Neville, J. Turiaf, J. Battesti et al., Course and prognosis of sarcoidosis around the world, The American Journal of Medicine, vol.57, issue.6, pp.847-852, 1974.
DOI : 10.1016/0002-9343(74)90160-0

Y. Inoue, N. Inui, D. Hashimoto, N. Enomoto, T. Fujisawa et al., Cumulative Incidence and Predictors of Progression in Corticosteroid-Na??ve Patients with Sarcoidosis, PLOS ONE, vol.36, issue.11, pp.143371-26575272, 2015.
DOI : 10.1371/journal.pone.0143371.t003

G. Ainslie and S. Benatar, Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy, Q J Med, vol.55, pp.253-270, 1985.

R. Baughman, R. Shipley, and C. Eisentrout, Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis, Lung, vol.135, issue.1, pp.371-377, 1987.
DOI : 10.7326/0003-4819-102-1-93

A. Prasse, C. Katic, M. Germann, A. Buchwald, G. Zissel et al., Phenotyping Sarcoidosis from a Pulmonary Perspective, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.3, pp.330-336, 2008.
DOI : 10.1183/09031936.00050106

R. Baughman, D. Culver, and M. Judson, A Concise Review of Pulmonary Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.5, pp.573-581, 2011.
DOI : 10.1007/s00467-005-2086-3

H. Biller, G. Zissel, B. Ruprecht, M. Nauck, B. Grawitz et al., Genotype-corrected reference values for serum angiotensin-converting enzyme, European Respiratory Journal, vol.28, issue.6, pp.1085-1090, 2006.
DOI : 10.1183/09031936.00050106
URL : http://erj.ersjournals.com/content/erj/28/6/1085.full.pdf

H. Israel, P. Karlin, H. Menduke, and O. Delisser, Factors Affecting Outcome of Sarcoidosis., Annals of the New York Academy of Sciences, vol.129, issue.1 Tenth Interna, pp.609-618, 1986.
DOI : 10.2214/ajr.117.4.777

M. Judson, A. Boan, and D. Lackland, The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States, Sarcoidosis Vasc Diffuse Lung Dis, vol.29, pp.119-127, 2012.

R. Baughman, A. Teirstein, M. Judson, M. Rossman, H. Yeager et al., Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.15, issue.10, pp.1885-1889, 2001.
DOI : 10.1016/0002-9343(71)90320-2

D. Rabin, B. Thompson, K. Brown, M. Judson, X. Huang et al., Sarcoidosis: social predictors of severity at presentation, European Respiratory Journal, vol.24, issue.4, pp.601-608, 2004.
DOI : 10.1183/09031936.04.00070503

M. Mirsaeidi, R. Machado, D. Schraufnagel, N. Sweiss, and R. Baughman, Racial Difference in Sarcoidosis Mortality in the United States, Chest, vol.147, issue.2, pp.438-449, 2015.
DOI : 10.1378/chest.14-1120

M. Tukey, J. Berman, D. Boggs, L. White, L. Rosenberg et al., Mortality Among African American Women With Sarcoidosis: Data From The Black Women's Health Study, C103. PATHOGENESIS, BIOMARKERS, AND RISK FACTORS FOR INTERSTITIAL LUNG DISEASE: FROM BENCH TO BEDSIDE, pp.128-133, 2013.
DOI : 10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A5183

R. Baughman, M. Judson, A. Teirstein, H. Yeager, M. Rossman et al., Presenting characteristics as predictors of duration of treatment in sarcoidosis, QJM, vol.99, issue.5, pp.307-315, 2006.
DOI : 10.1093/qjmed/hcl038

U. Costabel, F. Bonella, S. Ohshimo, J. Guzman, E. Bal et al., Diagnostic Modalities in Sarcoidosis: BAL, EBUS, and PET, Seminars in Respiratory and Critical Care Medicine, vol.31, issue.04, pp.404-408, 2010.
DOI : 10.1055/s-0030-1262207

R. Winterbauer, J. Lammert, M. Selland, R. Wu, D. Corley et al., Bronchoalveolar Lavage Cell Populations in the Diagnosis of Sarcoidosis, Chest, vol.104, issue.2, pp.352-361, 1993.
DOI : 10.1378/chest.104.2.352

H. Eule, A. Weinecke, I. Roth, and H. Wuthe, The Possible Influence of Corticosteroid Therapy on the Natural Course of Pulmonary Sarcoidosis., Annals of the New York Academy of Sciences, vol.71, issue.1 Tenth Interna, pp.695-701, 1986.
DOI : 10.1111/j.1749-6632.1986.tb18548.x